Results 21 to 30 of about 16,160 (225)

nvpinkham/Dysautonomia: Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia

open access: yes, 2022
R code used in "Gut microbiome dysbiosis drives metabolic dysfunction in Familial ...
Nick Pinkham
core   +1 more source

Apathy in Parkinson's Disease: Distinguishing Overlapping Symptoms Via Network Analysis. [PDF]

open access: yesMov Disord Clin Pract
Abstract Background Anxiety, fatigue, and excessive daytime sleepiness (EDS) frequently co‐occur in Parkinson's disease (PD) and can influence the clinical determination of apathy. Objective To distinguish patient‐reported apathy from other non‐motor symptoms.
Seemiller J   +6 more
europepmc   +2 more sources

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Kopinsky H   +5 more
europepmc   +2 more sources

Protocol of the Long-COVID Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients with Dysautonomia: The LoCoDiRe-Dys Study

open access: yesBioMed, 2023
Dysautonomia in the post-COVID-19 condition appears to affect a significant number of patients, with reports raising the incidence up to 61%, having an overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Dimitrios Spaggoulakis   +9 more
doaj   +1 more source

The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis

open access: yesFrontiers in Neurology, 2017
BackgroundMultiple system atrophy (MSA) is a rare, adult-onset, rapidly progressive fatal synucleinopathy that primarily affects oligodendroglial cells in the brain.
Carlos E. Mendoza-Santiesteban   +4 more
doaj   +1 more source

Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes

open access: yesnpj Parkinson's Disease, 2022
Non-motor symptoms of Parkinson’s disease (PD) such as dysautonomia and REM sleep behavior disorder (RBD) are recognized to be important prodromal symptoms that may also indicate clinical subtypes of PD with different pathogenesis.
Giulietta Maria Riboldi   +4 more
doaj   +1 more source

Therapeutic Approaches to Dysautonomia in Childhood, with a Special Focus on Long COVID

open access: yesChildren, 2023
Background: Dysautonomia seems to be important for the pathophysiology of psychosomatic diseases and, more recently, for long COVID. This concept may explain the clinical symptoms and could help open new therapeutic approaches.
Reiner Buchhorn
doaj   +1 more source

A Case of Leporine Dysautonomia from Croatia

open access: yesActa Veterinaria, 2022
Leporine dysautonomia (or dysautonomia of hares) is an idiopathic disorder associated with degeneration of neurons of the peripheral nervous system with loss of sympathetic and parasympathetic nerve function.
Huber Doroteja   +2 more
doaj   +1 more source

Tetanus Complicated by Dysautonomia: A Case Report and Review of Management

open access: yesCase Reports in Critical Care, 2021
Tetanus is a life-threatening infectious neurological disorder that is now a rare disease due to the institution of wide-spread vaccination strategies.
Nishant Sharma   +6 more
doaj   +1 more source

Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson’s Disease

open access: yesJournal of Parkinson’s Disease, 2021
Background: Olfactory or autonomic dysfunction is one of the earliest prodromal symptoms of Parkinson’s disease (PD). It has not been investigated whether PD patients have different phenotypes depending on the presence of these prodromal symptoms ...
Han Soo Yoo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy